Informational Manual Therapy to Improve Standing Balance

November 2, 2020 updated by: Rosa Cabanas Valdés, Universitat Internacional de Catalunya

The Effect of the Informational Manual Therapy for Improving Quiet Standing, Pain and Quality of Life in Healthy Individuals

Objectives: The aim of this study is to assess the effect of Informational Manual Therapy (IMT) on quiet standing and quality of life in healthy individuals. The IMT also is known as the Poyet-Pialoux method, is a holistic, no orthopedic, and soft manual therapy.

Design: This is a one-group pretest-posttest design. It is a within-subjects experiment in which each participant is tested first under the control condition and then under the treatment condition.

Setting: University laboratory. Intervention: One IMT session was performed on 57 healthy individuals aged from 18 to 65 years. They were grouped into three age groups. The treatment session was performed by 5 therapists on two days. The primary outcome was quite standing assessed by the SATEL force platform. Secondary outcomes were bodily pain assessed by the pain sections of the 36-Item Short Form Survey (SF-36) and quality of life by EQ-5D-3L (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). The primary outcome was evaluated before and immediately after treatment and after 7-10 days. The secondary outcomes were assessed after treatment and 3 weeks later.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Methods Study Design: The study has a one-group pretest-posttest design. The personal data of individuals were kept confidential and the data were shared anonymously upon request from the principal researcher. The TREND statement will be followed.

Subjects Fifty-seven participants will be recruited to participate in this study; the sample was one of convenience. The inclusion and exclusion criteria are as follows: age from 18 to 65 years old, not having a positive diagnosis for any disease which influences balance, no participation in any other trial, not suffering from an injury in the 3 months before the study or fractures in the previous 6 months, and no falls in the previous month. All individuals provided informed consent before enrolment.

Intervention All the participants received a single session of 30-45 min of IMT. All the treatment sessions took place at the UIC laboratory. The IMT session was performed over two days by four physiotherapists and a doctor. All have more than five years of experience in IMT treatment.

The first level of IMT was treated in this study: the objective is to harmonize the Cranio-sacral and sacro-pelvic systems, as this is fundamental for maintaining good posture. The first therapeutic maneuvers should be focused on releasing of the sacrum and the pelvis. The first is considered a key area for the correct transmission of forces and loads from the lower limbs to the upper limbs and vice versa and shares the role of rigid elements for this purpose (bones) and tensile elements (muscles, ligaments, fascia) in the whole body. At this level. Compensatory injuries that the body has started after a primary injury are treated on this level, through the Fluidic Chains. This also includes the treatment of some traumatic injuries, such as cranial strains, the compression of spheno-basilar synchondrosis, injuries of the pelvis and occipital bone, and damage to the flexion-extension and lateral displacement of the vertebrae. The diagnosis of this level is performed by cranial somotopias (reflex points on the skull and face). Practically all the treatment is carried out on the sacrum. The first step is the "fuses," which are vibration zones that act as a protection system for the body (1). These points sometimes stop working, which interrupts the correct movement of the PRM: 1st fuse: Inn-trang (on the forehead between the two eyebrows, the 4th sacral vertebra is stimulated if it is not adjusted). A massage on the scalp in several very soft circles that goes from the frontal to the occipital area is performed 6 times. 2nd fuse: 1st dorsal vertebra, 4th cervical, 4th dorsal, and 3rd lumbar. 3rd fuse: C0 (base of the occipital), a zone of the 2nd sacral vertebra, and the space between the spines of the 2nd and 3rd dorsal vertebrae and finally point R1 (between the 2nd and 3 rd metatarsal). If any point is blocked it is treated and harmonized with a soft touch towards the occipital.

Study Type

Interventional

Enrollment (Actual)

57

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Catalonia
      • Barcelona, Catalonia, Spain, 08195
        • Universitat Internacional de Catalunya

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Healthy people

Exclusion Criteria:

Not having problems with balance, Not suffering from an injury in the 3 months before the study, Not suffering from a fracture in the previous 6 month before the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Informational Manual Therapy
It is an integral no orthopedic and very soft manual therapy
The first level of IMT was treated in this study: the objective is to harmonize the cranio-sacral and sacro-pelvic systems, as this is fundamental for maintaining good posture. The first therapeutic maneuvers should be focused on releasing of the sacrum and the pelvis. The first is considered a key area for the correct transmission of forces and loads from the lower limbs to the upper limbs and vice versa and shares the role of rigid elements for this purpose (bones) and tensile elements (muscles, ligaments, fascia) in the whole body. In this level. Compensatory injuries that the body has started after a primary injury are treated on this level, through the Fluidic Chains. The diagnosis of this level is performed by cranial somotopias. Practically all the treatment is carried out on the sacrum. The first step are the "fuses," which are vibration zones which act as a protection system for the body. These points sometimes stop working, which interrupts the correct movement of the PRM.
Other Names:
  • Poyet-Pialoux method

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
static standing posture
Time Frame: baseline, pre-intervention
It was assessed using the force platform Satel 40 Hz model PF2002, software v 33.5 8C (France).
baseline, pre-intervention
static standing posture
Time Frame: immediately after the intervention
It was assessed using the force platform Satel 40 Hz model PF2002, software v 33.5 8C (France).
immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
How much bodily pain have you had during the past 4 weeks?
Time Frame: baseline, pre-intervention
by the 36-Item Short Form Survey (SF-36). 1 - None,2 - Very mild,3 - Mild, 4 - Moderate, 5 - Severe, - 6 very severe
baseline, pre-intervention
How much bodily pain have you had during the past 4 weeks?
Time Frame: three weeks, post-intervention
by the 36-Item Short Form Survey (SF-36). 1 - None,2 - Very mild,3 - Mild, 4 - Moderate, 5 - Severe, - 6 very severe
three weeks, post-intervention
During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)?
Time Frame: baseline, pre-intervention
by the 36-Item Short Form Survey (SF-36). 1 - Not at all, 2 - A little bit, 3 - Moderately, 4 - Quite a bit, 5 - Extremely
baseline, pre-intervention
During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)?
Time Frame: three weeks after treatment
by the 36-Item Short Form Survey (SF-36). 1 - Not at all, 2 - A little bit, 3 - Moderately, 4 - Quite a bit, 5 - Extremely
three weeks after treatment
mobility
Time Frame: baseline, pre-intervention
by the EQ-5D-3L questionnaire. Each dimension has 3 levels: no problems, some problems, and extreme problems
baseline, pre-intervention
mobility
Time Frame: three weeks post-intervention
by the EQ-5D-3L questionnaire.Each dimension has 3 levels: no problems, some problems, and extreme problems
three weeks post-intervention
self-care
Time Frame: baseline, pre-intervention
by the EQ-5D-3L questionnaire. Each dimension has 3 levels: no problems, some problems, and extreme problems
baseline, pre-intervention
self-care
Time Frame: three weeks post-intervention
by the EQ-5D-3L questionnaire.Each dimension has 3 levels: no problems, some problems, and extreme problems
three weeks post-intervention
usual activities
Time Frame: baseline, pre-intervention
by the EQ-5D-3L questionnaire. Each dimension has 3 levels: no problems, some problems, and extreme problems
baseline, pre-intervention
usual activities
Time Frame: three weeks post-intervention
by the EQ-5D-3L questionnaire. Each dimension has 3 levels: no problems, some problems, and extreme problems
three weeks post-intervention
pain/discomfort
Time Frame: baseline, pre-intervention
by the EQ-5D-3L questionnaire. Each dimension has 3 levels: no problems, some problems, and extreme problems
baseline, pre-intervention
pain/discomfort
Time Frame: three weeks post-intervention
by the EQ-5D-3L questionnaire. Each dimension has 3 levels: no problems, some problems, and extreme problems
three weeks post-intervention
anxiety/depression
Time Frame: baseline, pre-intervention
by the EQ-5D-3L questionnaire. Each dimension has 3 levels: no problems, some problems, and extreme problems
baseline, pre-intervention
anxiety/depression
Time Frame: three weeks post-intervention
by the EQ-5D-3L questionnaire. Each dimension has 3 levels: no problems, some problems, and extreme problems
three weeks post-intervention
visual analogue scale for health
Time Frame: baseline, pre-intervention
by the EQ-VAS, ranging from 0 ("worst possible") to 100 ("best possible").
baseline, pre-intervention
visual analogue scale for health
Time Frame: three weeks post-intervention
by the EQ-VAS, ranging from 0 ("worst possible") to 100 ("best possible").
three weeks post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rosa Cabanas Valdés, PhD, Universitat Internacional de Catalunya

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 1, 2020

Primary Completion (ACTUAL)

May 22, 2020

Study Completion (ACTUAL)

June 15, 2020

Study Registration Dates

First Submitted

May 17, 2020

First Submitted That Met QC Criteria

May 21, 2020

First Posted (ACTUAL)

May 28, 2020

Study Record Updates

Last Update Posted (ACTUAL)

November 4, 2020

Last Update Submitted That Met QC Criteria

November 2, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Poyet-Pialoux method

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is not any plan

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Manual Therapy

Subscribe